A randomized trial of tenapanor and phosphate binders as a dual-mechanism treatment for hyperphosphatemia in patients on maintenance dialysis (AMPLIFY)
Journal of the American Society of Nephrology | Apr 01, 2021
Journal of the American Society of Nephrology | Apr 01, 2021